TABLE 3.
Mapping of l(3)psg2, l(3)psg5, and l(3)psg7
| PSG loci | Alleles | Dominant marker mapping | Estimated position | Cytological deficiencies tested | Defined deficiencies tested |
|---|---|---|---|---|---|
| l(3)psg2 | 2300 | (Recombination within R and D) | ∼25 | Df(3L)BSC23 | Df(3L)ED4342 |
| 15203 | 1 ++, 28 R+, 42 + D | 66C–66D | Df(3L)HR119 | Df(3L)ED210 | |
| Df(3L)GN24 | Df(3L)Exel6104 | ||||
| Df(3L)ZN47 | Df(3L)Exel6105 | ||||
| Df(3L)XDI98 | Df(3L)Exel6106 | ||||
| Df(3L)BSC27 | Df(3L)Exel6107 | ||||
| Df(3L)BSC33 | Df(3L)Exel7210 | ||||
| Df(3L)pbl-X1 | Df(3L)ED212 | ||||
| Df(3L)ZP1 | |||||
| Df(3L)66C-G28 | |||||
| Df(3L)h-i22 | |||||
| Df(3L)BSC35 | |||||
| Df(3L)AC1 | |||||
| l(3)psg5 | 5307 | (Recombination within R and D) | ∼34 | Df(3L)BSC27 | Df(3L)Exel6112 |
| 9293 | 1 ++, 20 R+, 91 + D | 67E-F | Df(3L)BSC33 | Df(3L)ED4408 | |
| Df(3L)pbl-X1 | Df(3L)Exel6279 | ||||
| Df(3L)ZP1 | Df(3L)Exel8104 | ||||
| Df(3L)66C-G28 | |||||
| Df(3L)BSC13 | |||||
| Df(3L)h-i22 | |||||
| Df(3L)BSC35 | |||||
| Df(3L)AC1 | |||||
| Df(3L)BSC14 | |||||
| Df(3L)vin5 | |||||
| Df(3L)vin7 | |||||
| l(3)psg7 | 6753 | (Recombination within Sb and H) | ∼66 | Df(3R)Cha7 | Df(3R)Exel6178 |
| 14144 | 1 ++, 9 Sb+, 23 + H | 91F | Df(3R)DG4 | ||
| 16677 | Df(3R)LK19-1 |
The three mapped l(3)psg loci are listed on the left along with the alleles that define each lethal complementation group. One example of dominant marker mapping is provided, showing the number of recombinants recovered along with the estimated map position. All cytological and defined deficiencies used to map each locus are listed, with the noncomplementing deficiencies underlined.